Related Experiment Video
Updated: Jul 3, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Regulation of estrogen receptor alpha expression in human breast cancer cells by sulforaphane
Marcela Cortes Ramirez1, Keith Singletary
1Department of Food Science and Human Nutrition, University of Illinois, Urbana, 61801, USA.
Abstract:
Sulforaphane [SUL, 1-isothiocyanato-4-(methylsulfinyl)butane] is an isothiocyanate derived from glucoraphanin present in cruciferous vegetables, and it has a variety of potential chemopreventive actions. We analyzed the effects of SUL on the proliferation of human breast cancer cells and on the expression of estrogen receptor alpha (ERalpha) protein and mRNA in MCF-7 cells. Sulforaphane inhibited cell proliferation with IC(50) values at 24 and 48 h of 12.5 and 7.5 muM doses, respectively, and decreased ERalpha protein expression at concentrations between 2.5 and 30 muM. Inhibition of ERalpha protein expression was also accompanied by decreased progesterone receptor expression. MCF-7 ERalpha mRNA expression was inhibited by SUL at a dose of 30 muM, but not at lower SUL concentrations. At SUL doses <30 muM, the SUL-induced suppression of ERalpha protein was reversed by preincubation with the proteasome inhibitor MG132 and was accompanied by an increase in protein levels of the 20S catalytic core subunit PSMB5. Therefore, SUL can inhibit the expression of ERalpha protein in MCF-7 cells in part by inhibition of ERalpha mRNA transcription as well as by a mechanism that may involve increased proteasome-mediated degradation. These data provide new insights into mechanisms by which SUL inhibits proliferation of and down-regulates hormone receptor expression in MCF-7 cells.
Related Concept Videos
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
